Indivior Pharmaceuticals Inc (INDV) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
INDV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
INDV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 80.1% | 21.4% | 16.9% |
| 2024 | 80.6% | 2.7% | 0.2% |
| 2023 | 84.1% | -14.3% | -11.8% |
| 2022 | 83.2% | -9.0% | -4.9% |
| 2021 | 83.9% | 26.9% | 25.9% |
Download Data
Export INDV earnings history in CSV or JSON format
Free sign-in required to download data
Indivior Pharmaceuticals Inc (INDV) Earnings Overview
As of May 8, 2026, Indivior Pharmaceuticals Inc (INDV) reported trailing twelve-month net income of $251M, reflecting +10833.3% year-over-year growth. The company earned $1.95 per diluted share over the past four quarters, with a net profit margin of 16.9%.
Looking at the long-term picture, INDV's historical earnings data spans multiple years. The company achieved its highest annual net income of $263M in fiscal 2018.
Indivior Pharmaceuticals Inc maintains industry-leading profitability with a gross margin of 80.1%, operating margin of 21.4%, and net margin of 16.9%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including RBBN ($31M net income, 4.7% margin), AVPT ($47M net income, 8.4% margin), BHVN (-$648M net income), INDV has outperformed on profitability metrics. Compare INDV vs RBBN →
INDV Earnings vs Peers
Earnings metrics vs comparable public companies
INDV Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $210M | +10400.0% | $265M | $1.64 | 16.9% | 21.4% |
| 2024 | $2M | +101.6% | $32M | $0.01 | 0.2% | 2.7% |
| 2023 | -$129M | -193.2% | -$156M | $0.01 | -11.8% | -14.3% |
| 2022 | -$44M | -121.5% | -$81M | $-0.37 | -4.9% | -9.0% |
| 2021 | $205M | +238.5% | $213M | $1.31 | 25.9% | 26.9% |
| 2020 | -$148M | -210.4% | -$156M | $-1.08 | -22.9% | -24.1% |
| 2019 | $134M | -49.0% | $178M | $0.92 | 17.1% | 22.7% |
| 2018 | $263M | +331.1% | $317M | $1.75 | 27.4% | 33.0% |
| 2017 | $61M | +90.1% | $423M | $0.41 | 5.3% | 36.9% |
| 2016 | $32M | - | $338M | $0.22 | 3.3% | 34.9% |
See INDV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INDV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INDV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINDV — Frequently Asked Questions
Quick answers to the most common questions about buying INDV stock.
Is INDV growing earnings?
INDV EPS is $1.95, with earnings growth accelerating to +10833.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $251M.
What are INDV's profit margins?
Indivior Pharmaceuticals Inc net margin is +16.9%, with operating margin at +21.4%. Above-average margins indicate pricing power.
How consistent are INDV's earnings?
INDV earnings data spans 2016-2025. The accelerating earnings trend is +10833.3% YoY. Historical data enables comparison across business cycles.